Innoviva, Inc. INVA
Set alert
As of Nov 2, 2:25 PM ET
- YTD
- +5.80%
- 1 year
- +16.21%
- Open
- 21.62
- Prev close
- 21.22
- Mkt cap
- 1.53B
- Vol
- 288.06K
- Avg vol
- 777.46K
- EPS
- 4.28
- P/E
- 4.94
- Div yield
- 0.00%
More statistics
- Low
- 20.89
- High
- 21.62
- Forward P/E
- 9.60
- Beta
- 0.38
- Short ratio
- 7.44
- Inst. own
- 109.03%
- Dividend
- 0.00
- Ex-div date
- Sep 7, 2015
- Earnings
- Nov 4, 2026
- 50-d avg
- 20.99
- 200-d avg
- 21.88
- 1y target
- 35.00
News
2 weeks ago businesswire.com
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced today it will present data from four abstracts at IDWeek 2026, the…
3 weeks ago zacks.com
Do Options Traders Know Something About Innoviva Stock We Don't?
Investors need to pay close attention to INVA stock based on the movements in the options market lately.
3 weeks ago zacks.com
INVA vs. MRK: Which Stock Is the Better Value Option?
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Innoviva (INVA) or Merck (MRK). But which of these two stocks is more attractive to value investors?
3 weeks ago zacks.com
5 Attractive Low Price-to-Sales Stocks With Promising Upside Potential
DINO, INVA, PARR, GNW and PBF stand out as low price-to-sales stocks with promising upside potential. Discover how attractive valuations can uncover hidden value.
3 weeks ago zacks.com
Should Value Investors Buy Innoviva (INVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
4 weeks ago invezz.com
Russian plague outbreak could boost these under-the-radar pharma stocks
Global biosecurity alarms are flashing after an incident at an anti-plague research facility in Siberia sparked a severe public health response. Following the fatal lab exposure of a researcher in…
-
1 month ago benzinga.com
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35
Oppenheimer analyst Les Sulewski assumes Innoviva (NASDAQ:INVA) with a Outperform rating and announces Price Target of $35.
1 month ago defenseworld.net
Reviewing Innoviva (NASDAQ:INVA) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Innoviva (NASDAQ: INVA - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the…
1 month ago defenseworld.net
Baird Financial Group Inc. Makes New $6.23 Million Investment in Innoviva, Inc. $INVA
Baird Financial Group Inc. acquired a new stake in Innoviva, Inc. (NASDAQ: INVA) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission…
2 months ago gurufocus.com
Innoviva to Participate in Upcoming Investor Conferences
Innoviva, Inc. (NASDAQ: INVA) (âInnovivaâ or the âCompanyâ), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical
2 months ago defenseworld.net
Hsbc Holdings PLC Buys Shares of 49,428 Innoviva, Inc. $INVA
Hsbc Holdings PLC acquired a new position in Innoviva, Inc. (NASDAQ: INVA) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 49,428…
2 months ago businesswire.com
Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, Inc. (NASDAQ: INVA), announced today that three of the company's infectious disease therapies,…
-
2 months ago benzinga.com
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34
Cantor Fitzgerald analyst Steve Seedhouse maintains Innoviva (NASDAQ:INVA) with a Overweight and lowers the price target from $36 to $34.
2 months ago seekingalpha.com
Innoviva: The Royalty Decline Is Real, But The Valuation Is Too Pessimistic
Innoviva is a company that is transitioning from a pure royalty-based business to a diversified healthcare company with commercial products and strategic assets. I have rated Innoviva as a buy with a…
2 months ago zacks.com
Innoviva (INVA) Q2 Earnings and Revenues Top Estimates
Innoviva (INVA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.77 per share a year ago.
-
2 months ago benzinga.com
Innoviva Q2 EPS $(1.14) Misses $0.40 Estimate, Sales $119.600M Beat $110.985M Estimate
Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $0.40 by 385 percent. This is a 248.05 percent decrease over earnings of $0.77 per…
2 months ago businesswire.com
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and…
3 months ago marketbeat.com
Supernus Pharmaceuticals Q2 Earnings Call Highlights
Supernus Pharmaceuticals NASDAQ: SUPN and Indivior Pharmaceuticals announced a proposed all-stock, tax-free merger of equals that would create a central nervous system-focused biopharmaceutical…
3 months ago defenseworld.net
Dimensional Fund Advisors LP Acquires 76,026 Shares of Innoviva, Inc. $INVA
Dimensional Fund Advisors LP grew its holdings in shares of Innoviva, Inc. (NASDAQ: INVA) by 1.7% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned…
4 months ago gurufocus.com
Nortiva Bio Launches to Develop Long-Acting Oral Medicines
Nortiva Bio, Inc. (âNortivaâ) today announced its launch as a clinical-stage biopharmaceutical company dedicated to developing long-acting oral medicines u
-
4 months ago benzinga.com
Nortiva Bio Launches Clinical-Stage Biopharmaceutical Company To Develop Long-Acting Oral Medicines
Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptiveCompany seeks pipeline expansion via…
4 months ago businesswire.com
Nortiva Bio Launches to Develop Long-Acting Oral Medicines
LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a clinical-stage biopharmaceutical company dedicated to developing long-acting oral medicines using its…
-
4 months ago benzinga.com
Innoviva Specialty Therapeutics Inks Agreement With Dr. Reddy's Laboratories To Develop, Commercialize XACDURO To Treat Bacterial Pneumonia
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that it has entered into an exclusive distribution and licensing agreement with Dr. Reddy's…
4 months ago businesswire.com
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that it has entered into an exclusive distribution and licensing…
4 months ago seekingalpha.com
Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
-
5 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $46 price target.
1 year ago benzinga.com
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday
1 year ago benzinga.com
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
1 year ago benzinga.com
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 497 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 100 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 1076 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 507 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 126 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 122 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 529 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 273 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 132 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 108 companies set new 52-week lows.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 137 companies made new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 159 companies achieved new highs for the year.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 101 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 154 stocks made new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday